» Authors » Brian J Bartholmai

Brian J Bartholmai

Explore the profile of Brian J Bartholmai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 2431
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Fanni S, Colligiani L, Volpi F, Novaria L, Tonerini M, Airoldi C, et al.
J Clin Med . 2024 Dec; 13(23). PMID: 39685766
To investigate the relationship between COVID-19 pneumonia outcomes and three chest CT analysis approaches. Patients with COVID-19 pneumonia who underwent chest CT were included and divided into survivors/non-survivors and intubated/not-intubated....
2.
Koo C, Huls S, Baffour F, McCollough C, Yu L, Bartholmai B, et al.
J Thorac Imaging . 2024 Oct; PMID: 39445384
Purpose: Compare the impact of photon-counting detector computed tomography (PCD-CT) to conventional CT on an interstitial lung disease (ILD) quantitative machine learning (QML) model. Materials And Methods: A QML model...
3.
Zaremba S, Miller A, Ovrom E, Senefeld J, Wiggins C, Dominelli P, et al.
J Appl Physiol (1985) . 2024 Sep; 137(5):1168-1174. PMID: 39298620
Coronavirus disease 2019 (COVID-19) is associated with enlarged luminal areas of large conducting airways. In 10-30% of patients with acute COVID-19 infection, symptoms persist for more than 4 wk (referred...
4.
Gonzalez T, Roden A, Bartholmai B, Lindell R
Radiol Case Rep . 2024 Jul; 19(9):3763-3769. PMID: 38983277
Pulmonary light chain deposition disease is a rare entity characterized by immunoglobulin deposition within the lung parenchyma with pathologic features distinct from pulmonary amyloidosis. Here, the authors present the clinical...
5.
Lu R, Gregory A, Suryadevara R, Xu Z, Jain D, Morrow J, et al.
Am J Respir Crit Care Med . 2024 Jun; PMID: 38935868
Rationale: While many studies have examined gene expression in lung tissue, the gene regulatory processes underlying emphysema are still not well understood. Finding efficient non-imaging screening methods and disease-modifying therapies...
6.
Woodworth C, Frota Lima L, Bartholmai B, Koo C
Clin Chest Med . 2024 May; 45(2):249-261. PMID: 38816086
Early detection with accurate classification of solid pulmonary nodules is critical in reducing lung cancer morbidity and mortality. Computed tomography (CT) remains the most widely used imaging examination for pulmonary...
7.
John J, Clark A, Kumar H, Burrowes K, Vandal A, Wilsher M, et al.
Acad Radiol . 2024 Apr; 31(11):4650-4660. PMID: 38679527
Rationale And Objectives: Fibrotic scarring in idiopathic pulmonary fibrosis (IPF) typically develops first in the posterior-basal lung tissue before advancing to involve more of the lung. The complexity of lung...
8.
Bertilacchi M, Piccarducci R, Celi A, Germelli L, Romei C, Bartholmai B, et al.
Biomed J . 2024 Apr; 47(6):100723. PMID: 38583585
Background: COVID-19 reduces lung functionality causing a decrease of blood oxygen levels (hypoxemia) often related to a decreased cellular oxygenation (hypoxia). Besides lung injury, other factors are implicated in the...
9.
Fanni S, Volpi F, Colligiani L, Chimera D, Tonerini M, Pistelli F, et al.
Diagnostics (Basel) . 2024 Mar; 14(5). PMID: 38473022
Background: To quantitatively evaluate CT lung abnormalities in COVID-19 survivors from the acute phase to 24-month follow-up. Quantitative CT features as predictors of abnormalities' persistence were investigated. Methods: Patients who...
10.
Chan H, Weatherley N, Biancardi A, Johns C, Tahir B, Karwoski R, et al.
Diagnostics (Basel) . 2023 Dec; 13(23). PMID: 38066737
The patterns of idiopathic pulmonary fibrosis (IPF) lung disease that directly correspond to elevated hyperpolarised gas diffusion-weighted (DW) MRI metrics are currently unknown. This study aims to develop a spatial...